Efficacy and Safety of Sintilimab in Combination with Concurrent Chemoradiotherapy for Locally Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (SHARED): Study Protocol of a Prospective, Multi-Center, Single-Arm Phase 2 Trial

Efficacy and Safety of Sintilimab in Combination with Concurrent Chemoradiotherapy for Locally Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (SHARED): Study Protocol of a Prospective, Multi-Center, Single-Arm Phase 2 Trial

Jia Wei,1 Xiaofeng Lu,2 Qin Liu,1 Yao Fu,3 Song Liu,4 Lin Li,3 Fangcen Liu,3 Xiangshan Fan,3 Ju Yang,1 Yang Yang,1 Yang Zhao,5 Wenxian Guan,2 Baorui Liu1 1The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University & Clinical Cancer Institute of Nanjing Universit...

Full description

Bibliographic Details
Main Authors: Wei J, Lu X, Liu Q, Fu Y, Liu S, Li L, Liu F, Fan X, Yang J, Yang Y, Zhao Y, Guan W, Liu B
Format: Article
Language:English
Published: Dove Medical Press 2022-06-01
Series:Cancer Management and Research
Subjects:
anti-pd-1
induction chemotherapy
chemoradiotherapy
immunotherapy
Online Access:https://www.dovepress.com/efficacy-and-safety-of-sintilimab-in-combination-with-concurrent-chemo-peer-reviewed-fulltext-article-CMAR

Internet

https://www.dovepress.com/efficacy-and-safety-of-sintilimab-in-combination-with-concurrent-chemo-peer-reviewed-fulltext-article-CMAR

Similar Items